期刊文献+

狼疮性肾炎肾血管损害和miR-145的表达 被引量:7

Renal vascular damage and the expression of miR-145 in lupus nephritis
下载PDF
导出
摘要 目的评估狼疮性肾炎(LN)患儿肾血管损害(RVLs)并检测肾血管中mi R-145的表达。方法收集41例经肾活检证实为LN的系统性红斑狼疮(SLE)患儿的临床资料,评估肾小球损害和RVLs。根据RVLs评分及病理类型分组。采用原位杂交法检测mi R-145在肾血管中的表达。比较不同病理分型组间RVLs、肾血管mi R-145表达及肾小球损害评分差异;比较不同RVLs组间临床指标、肾小球损害评分及肾血管mi R-145表达差异。结果不同LN病理类型间,RVLs的差异无统计学意义(P>0.05),肾血管mi R-145表达及肾小球损害评分差异有统计学意义(P<0.01)。不同RVLs组间,临床指标及肾小球损害差异均无统计学意义(P>0.05),而肾血管mi R-145表达差异有统计学意义(P<0.01)。结论 LN患儿存在RVLs,mi R-145可能参与RVLs的发生机制。 Objective To evaluate renal vascular damage (RVLs) and detect the expression of miR-145 in children with lupus nephritis (LN).Methods Clinical data of 41 cases of LN diagnosed by renal biopsy from the children with systemic lupus erythematosus (SLE) were collected. Glomerular damage score and RVLs were evaluated. The children were divided into groups according to RVLs score and pathological pattern. In situ hybridization was performed to detect the expression of miR-145 in kidney blood vessel. Differences in RVLs, miR-145 expression in the renal blood vessels and glomerular damage score were observed among the groups with different renal pathological pattern. Differences in clinical parameters, glomerular damage score and miR-145 expression in the renal blood vessels were investigated among groups with different RVLs. Results Among the groups with different pathological pattern, there was no difference in RVLs (P>?0.05) while signiifcant different were found in the expression of miR-145 and glomerular damage score (P?<?0.01). Among the groups with different RVLs, both clinical indexes and glomerular damage score were similar (P?>?0.05) while a statistical different was found in the expression of miR-145 (P?<?0.01). Conclusions Children with LN had RVLs and the miR-145 may be involved in development of RVLs.
出处 《临床儿科杂志》 CAS CSCD 北大核心 2016年第6期406-410,共5页 Journal of Clinical Pediatrics
关键词 狼疮性肾炎 肾血管损害 MIR-145 lupus nephritis renal vascular damage miR-145
  • 相关文献

参考文献21

  • 1Appel GB, Pirani CL, D’Agati V. Renal vascular complicationsof systemic lupus erythematosus [J]. Am Soc Nephrol,1994, 4(8): 1499-1515.
  • 2Descombes E, Droz D, Drouet L, et al. Renal vascular lesionsin lupus nephritis [J]. Medicine (Baltimore) , 1997, 76(5):355-368.
  • 3Banfi G, Bertani T, Boeri V, et al. Renal vascular lesions asa marker of poor prognosis in patients with lupus nephritis.Groppo Italiano per lo Studio della Nefrite Lupica (GISNEL)[J]. Am J Kidney Dis, 1991, 18(2): 240-248.
  • 4Davis-Dusenbery B, Wu C, Hata A. Micromanaging vascularsmooth muscle cell differentiation and phenotypic modulation[J]. Arterioscler Thromb Vasc Biol, 2011, 31(11): 2370-2377.
  • 5Rangrez AY, Massy ZA, Metzinger-Le Meuth V, et al. miR-143 and miR-145: molecular keys to switch the phenotypeof vascular smooth muscle cells [J]. Circ Cardiovasc Genet,2011, 4(2): 197-205.
  • 6Cordes KR, Sheehy NT, White MP, et al. miR-145 andmiR-143 regulate smooth muscle cell fate and plasticity [J].Nature, 2009, 460(7256): 705-710.
  • 7Boettger T, Beetz N, Kostin S, et al. Acquisition of thecontractile phenotype by murine arterial smooth muscle cellsdepends on the Mir143/145 gene cluster [J]. J Clin Invest,2009, 119(9): 2634-2647.
  • 8Wei Y, Nazari-Jahantigh M, Neth P, et al. MicroRNA-126,-145, and -155: a therapeutic triad in atherosclerosis- [J].Arterioscler Thromb Vasc Biol, 2013, 33(3): 449-454.
  • 9Lovren F, Pan Y, Quan A, et al. MicroRNA-145 targetedtherapy reduces atherosclerosis [J]. Circulation, 2012, 126(11Suppl 1): S81-90.
  • 10Hochberg MC. Updating the American College ofRheumatology revised criteria for the classification ofsystemic lupus erythematosus [J]. Arthritis Rheum, 1997,40(9):1725.

同被引文献30

引证文献7

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部